Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
22.96
+0.43 (1.91%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Employees
Assembly Biosciences had 73 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
73
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$973,932
Profits / Employee
-$87,438
Market Cap
455.00M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| 4D Molecular Therapeutics | 196 |
| Sutro Biopharma | 133 |
| Neurogene | 131 |
| C4 Therapeutics | 104 |
| Prelude Therapeutics | 79 |
| Prothena Corporation | 67 |
| AgomAb Therapeutics NV | 62 |
| Contineum Therapeutics | 51 |
ASMB News
- 6 days ago - Assembly Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 10 days ago - Assembly Biosciences Transcript: AGM 2026 - Transcripts
- 11 days ago - Assembly Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 17 days ago - Assembly Biosciences Announces Upcoming Investor Conference Presentations - GlobeNewsWire
- 19 days ago - Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 23 days ago - Assembly Biosciences announces expansion of ABI-6250 clinical development - TheFly
- 23 days ago - Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 23 days ago - Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases - GlobeNewsWire